Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China.
Key Laboratory of Luminescence Analysis and Molecular Sensing, Southwest University, Ministry of Education, College of Pharmaceutical Sciences, Chongqing 400715, People's Republic of China.
Toxicol Appl Pharmacol. 2020 Nov 15;407:115241. doi: 10.1016/j.taap.2020.115241. Epub 2020 Sep 13.
Neurological diseases were often characterized by progressive neuronal death, and emerging evidences suggested that ferroptosis may be an active driver of multiple neurodegenerative diseases. However, the mechanisms underlying ferroptosis in neuron cells are unclear. Here, we demonstrated that ferroptotic stimuli caused injury in neuron-like PC12 cells by modulating the expression of proteins involved in iron metabolism and lipid peroxidation at multiple levels, such as altering iron import/export, activating ferritinophagy, and decreasing glutathione (GSH) level. Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates multiple genes involved in ferroptosis, however, its exact role remain elusive. Our mechanistic inquiry revealed that Nrf2 expression enhanced iron storage capacity by increasing ferritin heavy chain 1 (FTH1) expression in PC12 cells. Moreover, Nrf2 alleviated the decrease in GSH level by promoting the expression of genes related to GSH synthesis, including solute carrier family 7 member 11 (SLC7A11) and cysteine ligase (GCL). The contribution of Nrf2 on ferroptosis resistance was further verified by increasing cell tolerance to oxidative stress. Furthermore, Nfe2l2 (Nrf2) knockdown sensitized cells to ferroptotic cell death. Taken together, our findings suggested that iron accumulation caused by altering iron metabolism and the decrease of GSH content are key factors in determining ferroptosis in PC12 cells, and Nrf2 inhibits ferroptosis by combating iron-induced oxidative stress. Our present study provided new clues for the intervention and prevention against ferroptosis-associated neurological diseases.
神经疾病通常表现为进行性神经元死亡,新出现的证据表明铁死亡可能是多种神经退行性疾病的一个活跃驱动因素。然而,神经元细胞中铁死亡的机制尚不清楚。在这里,我们证明铁死亡刺激通过调节铁代谢和脂质过氧化相关蛋白的表达在多个层面上引起神经元样 PC12 细胞损伤,例如改变铁的输入/输出、激活铁蛋白自噬和降低谷胱甘肽 (GSH) 水平。核因子红细胞 2 相关因子 2 (Nrf2) 调节铁死亡涉及的多个基因,但它的确切作用仍不清楚。我们的机制研究表明,Nrf2 通过增加 PC12 细胞中铁蛋白重链 1 (FTH1) 的表达来增强铁储存能力。此外,Nrf2 通过促进与 GSH 合成相关的基因的表达,包括溶质载体家族 7 成员 11 (SLC7A11) 和半胱氨酸连接酶 (GCL),来减轻 GSH 水平的降低。通过增加细胞对氧化应激的耐受能力,进一步验证了 Nrf2 对铁死亡抵抗的贡献。此外,Nfe2l2 (Nrf2) 敲低使细胞对铁死亡细胞死亡敏感。总之,我们的研究结果表明,改变铁代谢和 GSH 含量的降低导致铁积累是决定 PC12 细胞铁死亡的关键因素,Nrf2 通过对抗铁诱导的氧化应激来抑制铁死亡。我们的研究为干预和预防铁死亡相关的神经疾病提供了新的线索。